MDA Engage: Myasthenia Gravis Symposium
September 18, 2021
Time: 11:00am - 4:45pm Eastern Time
Virtual, online event
There is no cost to members of the MDA community or healthcare providers to attend the event, however registration is required. Members of the biopharma industry interested in sponsoring or attending should contact the MDA Healthcare Partnerships team at MDAPartners@mdausa.org. For all other questions, please reach out to mdaengage@mdausa.org.
Watch Now
Agenda
- Welcome and Introductions (11:00am ET)
- Nicole Petrouski, Muscular Dystrophy Association
- Research and Clinical Trials for MG (11:15am ET)
- Dr. Jeff Guptill, Associate Professor of Neurology, Duke University
- Drug Development Discussion (12:10pm ET)
- MDA Mission Spotlight (12:45pm ET)
- Nicole Petrouski, Muscular Dystrophy Association
- Updates on Treatments for MG (1:10pm ET)
- Dr. Pushpa Narayanaswami, FAAN, Associate Professor of Neurology Harvard Medical School
- Crisis and Emergency Management with MG (2:00pm ET)
- Dr. Allan Weiss, Neurologist, St. Anthony’s Neurology Group
- Effects of Psychological Factors with MG (3:00pm ET)
- Dr. Robert Paul, PhD, ABPP-CN, Executive Director, Missouri Institute of Mental Health, Professor, University of Missouri, St. Louis
- Comparing therapies and Their Side Effects, what causes them- remission? (3:50pm ET)
- Dr. Michael Hehir, Neurologist, Associate Professor University of Vermont Medical Center
For questions reach out to: mdaengage@mdausa.org | 1-833-ASK-MDA1 (1-833-275-6321)